Euroscape Column in Business Line

Mohan,

You are the CENTRE PIECE in to-day's Business Line. With your picture also there, it has come out very well, and very prominently. I do not find BSR writing for the last few days. I hope he is well. Such a good writer, totally outspoken and unbiassed.

Congrats. Keep it up. Next piece can be on the Supreme Court judgment regarding the patent for Glyvek (Cancer drug) in the Novartis case. The Company says it will be doomsday for R&D in India. What is the reaction, internationally. How do European Union contend with the price exploitation with regard to life-saving drugs? Can be an interesting and enlightening subject. You can also suggest that people like Bill Gates should fund R&D in such areas and let any one make the medicines, as long as they are priced humanely. This will be an extension of CSR concept itself.

Appa

K.V.narayanmurti

10.04.2013